Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | BCHE | P06276 | 4/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL8975730 | 0.85 | BCHE (0.40) | ACHEBCHENPY5RMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL8976067 | 0.81 | NSD2 (0.34) | NPY5RNSD2NR2F2 | |
| Trifluoromethanesulfonic Acid SCHEMBL8975799 | 0.81 | BCHE (0.35) | ACHEBCHEMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL8976385 | 0.78 | — | — | |
| SCHEMBL8976156 | 0.75 | ACHE (0.43) | ACHEBCHEMAPT | |
| SCHEMBL17940516 | 0.70 | ACHE (0.67) | ACHEBCHEGRIN1GRIN2AGRIN2B | |
| SCHEMBL8975697 | 0.70 | BCHE (0.37) | ACHEBCHEMAPT | |
| SCHEMBL17940525 | 0.65 | ACHE (0.65) | ACHEBCHEGRIN1GRIN2AGRIN2B | |
| Trifluoromethanesulfonic Acid SCHEMBL9565483 | 0.64 | KCNH2 (0.33) | ACHEMAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL20495503 | 0.64 | KCNH2 (0.35) | ACHENSD2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532261-A | TREATING STAPHYLOCOCCUS INFECTIONS | MERCK & CO., INC. (US) | 1996-07-02 | — | — | US | disclosed |